Home > Clonidine trialled in new anti-relapse role for heroin dependence.

[Drug and Alcohol Findings] (2016) Clonidine trialled in new anti-relapse role for heroin dependence. Drug and Alcohol Findings Bulletin (11 April 2016)

URL: http://findings.org.uk/PHP/dl.php?file=Kowalczyk_W...

From the USA the first study to show that the drug clonidine can not only ease withdrawal from heroin but also help prevent relapse, seemingly by moderating stress-related craving for the drug.

Key points from summary and commentary
• Clonidine is a medication commonly used to ease heroin withdrawal, but it may also help prevent resumption of heroin use by avoiding stress-related craving for the drug.
• The first study to test this theory found that buprenorphine-maintained patients allocated at random to clonidine were on some measures less likely to use illicit opiate-type drugs and less likely to experience craving for heroin associated with stress or poor mood.
• This single study has not yet established that in routine practice clonidine will prove useful in this new role; in other circumstances patients may simply not take the pills.


Item Type:Evidence resource
Publication Type:Review
Drug Type:Opioid
Intervention Type:AOD disorder drug therapy, AOD disorder treatment method, Rehabilitation/Recovery
Source:Drug and Alcohol Findings
Date:April 2016
Number:11 April 2016
EndNote:View
Subjects:A Substance use, abuse, and dependence > Natural history of substance use > Relapse
B Substances > Opioids (opiates)
B Substances > Opioids (opiates) > Heroin
HJ Treatment method > Substance disorder treatment method > Substance disorder drug therapy
HJ Treatment method > Substance disorder treatment method > Substance disorder relapse prevention method
VA Geographic area > United States

Repository Staff Only: item control page